![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Bladder Cancer |
Free Subscription
1 Ann Oncol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Bladder Cancer is free of charge.
FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor
pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced
malignancies.
Ann Oncol. 2022;33:522-533.
PubMed
Abstract available
CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of
bladder carcinoma through modulating the miR-498/murine double minute-2 axis.
Bioengineered. 2022;13:10734-10748.
PubMed
Abstract available
Hybridization chain reaction-mediated Fe2MoO4 bimetallic nanozyme for
colorimetric risk prediction of bladder cancer.
Biosens Bioelectron. 2022;210:114272.
PubMed
Abstract available
Systematic review of the association between socioeconomic status and bladder
cancer survival with hospital type, comorbidities, and treatment delay as
mediators.
BJUI Compass. 2021;2:140-158.
PubMed
Abstract available
Bladder cancer biomarkers: Past and future directions.
BJUI Compass. 2021;2:7-8.
PubMed
Long-term outcomes of outpatient laser ablation for recurrent non-muscle invasive
bladder cancer: A retrospective cohort study.
BJUI Compass. 2021;3:124-129.
PubMed
Abstract available
Rationale and design of a prospective, multicenter, phase II clinical trial of
safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus
tislelizumab followed by total mesorectal excision for locally advanced rectal
cancer (NCRT
BMC Cancer. 2022;22:462.
PubMed
Abstract available
SBSN drives bladder cancer metastasis via EGFR/SRC/STAT3 signalling.
Br J Cancer. 2022 Apr 28. pii: 10.1038/s41416-022-01794.
PubMed
Abstract available
Secondary bladder cancer during long-term follow-up after iodine-125 permanent
seed implantation for localized prostate cancer.
Brachytherapy. 2022 Apr 20. pii: S1538-4721(22)00037.
PubMed
Abstract available
Addition of Nintedanib to Neoadjuvant Chemotherapy Is Safe in Bladder Cancer.
Cancer Discov. 2022 Apr 29:OF1. doi: 10.1158/2159-8290.CD-RW2022.
PubMed
Abstract available
Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic
Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:35-42.
PubMed
Abstract available
Safety and Efficacy of Reproductive Organ-Sparing Radical Cystectomy in Women
With Variant Histology and Advanced Stage.
Clin Genitourin Cancer. 2022;20:60-68.
PubMed
Abstract available
Discordance Between Clinical and Pathological Staging and Grading in Upper Tract
Urothelial Carcinoma.
Clin Genitourin Cancer. 2022;20:95.
PubMed
Abstract available
Outcomes of metastatic urothelial carcinoma following discontinuation of
enfortumab-vedotin.
Clin Genitourin Cancer. 2022;20:11-16.
PubMed
Abstract available
Histological Variants of Urothelial Carcinoma Predict No Response to Neoadjuvant
Chemotherapy.
Clin Genitourin Cancer. 2022;20:e1-e6.
PubMed
Abstract available
Validation of Prognostic Scores in Patients With Metastatic Urothelial Cancer
Enrolling in Phase I Targeted Therapy or Next Generation Immunotherapy Trials.
Clin Genitourin Cancer. 2022;20:e16-e24.
PubMed
Abstract available
Robot-assisted radical cystectomy: surgical technique, perioperative and
oncologic outcomes.
Curr Opin Urol. 2022;32:116-122.
PubMed
Abstract available
Lynch syndrome in urological practice: diagnosis, therapeutic strategies, and
screening for upper tract urothelial carcinoma.
Curr Opin Urol. 2022;32:40-47.
PubMed
Abstract available
Molecular intricacies of upper tract urothelial carcinoma and their relevance for
therapy considerations.
Curr Opin Urol. 2022;32:48-53.
PubMed
Abstract available
Severe Respiratory Failure Due to Pulmonary BCGosis in a Patient Treated for
Superficial Bladder Cancer.
Diagnostics (Basel). 2022;12.
PubMed
Abstract available
[BCG-therapy as a rare reason for postrenal failure].
Dtsch Med Wochenschr. 2022;147:403-406.
PubMed
Abstract available
Detecting the muscle invasiveness of bladder cancer: An application of diffusion
kurtosis imaging and tumor contact length.
Eur J Radiol. 2022;151:110329.
PubMed
Abstract available
Evid Based Complement Alternat Med
The DeltaN p63 Promotes EMT and Metastasis in Bladder Cancer by the PTEN/AKT
Signalling Pathway.
Evid Based Complement Alternat Med. 2022;2022:9566055.
PubMed
Abstract available
Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder.
Expert Rev Anticancer Ther. 2022;22:259-267.
PubMed
Abstract available
Avelumab in locally advanced or metastatic urothelial carcinoma.
Expert Rev Anticancer Ther. 2022;22:135-140.
PubMed
Abstract available
Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in
Muscle-Invasive Bladder Cancer.
Front Immunol. 2022;13:782982.
PubMed
Abstract available
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder
Cancer.
Front Oncol. 2022;12:846958.
PubMed
Abstract available
Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With
T2DM: An Updated Meta-Analysis.
Front Pharmacol. 2022;13:865988.
PubMed
Abstract available
Identification of Bladder Cancer Subtypes Based on Necroptosis-Related Genes,
Construction of a Prognostic Model.
Front Surg. 2022;9:860857.
PubMed
Abstract available
Differential Expression Profiles and Bioinformatics Analysis of tRNA-Derived
Small RNAs in Muscle-Invasive Bladder Cancer in a Chinese Population.
Genes (Basel). 2022;13.
PubMed
Abstract available
G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of
Chemotherapy and Immunotherapy in Bladder Cancer.
Genes (Basel). 2022;13.
PubMed
Abstract available
[Laparoscopic Radical Cystectomy with Ileal Neobladder for Metachronous Bladder
Cancer Following Laparoscopic Radical Prostatectomy : A Case Report].
Hinyokika Kiyo. 2022;68:87-90.
PubMed
Abstract available
LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to
temozolomide through MGMT-related DNA damage pathways.
Hum Pathol. 2022;123:59-73.
PubMed
Abstract available
Metabolomic Approaches for Detection and Identification of Biomarkers and Altered
Pathways in Bladder Cancer.
Int J Mol Sci. 2022;23.
PubMed
Abstract available
Ascorbic acid-2 glucoside mitigates intestinal damage during pelvic radiotherapy
in a rat bladder tumor model.
Int J Radiat Biol. 2022;98:942-957.
PubMed
Abstract available
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict
Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.
Int J Surg Pathol. 2022 Apr 24:10668969221095173. doi: 10.1177/10668969221095173
PubMed
Abstract available
Piperlongumine increases the sensitivity of bladder cancer to cisplatin by
mitochondrial ROS.
J Clin Lab Anal. 2022 Apr 25:e24452. doi: 10.1002/jcla.24452.
PubMed
Abstract available
A Nomogram Model to Predict Recurrence of Non-Muscle Invasive Bladder Urothelial
Carcinoma After Resection Based on Clinical Parameters and Immunohistochemical
Markers.
J Invest Surg. 2022;35:1186-1194.
PubMed
Abstract available
Three-Dimensional Conformal Radiotherapy Combined with Gemcitabine and Docetaxel
in the Treatment of Advanced Bladder Cancer and Its Effects on Inflammatory
Factors and Immune Function.
J Oncol. 2022;2022:9347218.
PubMed
Abstract available
Thrombotic Thrombocytopenic Purpura associated with Pembrolizumab.
J Oncol Pharm Pract. 2022;28:979-982.
PubMed
Abstract available
Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and
Perioperative Outcomes Among Patients With Bladder Cancer in Sweden.
JAMA Netw Open. 2022;5:e228959.
PubMed
Abstract available
Significant impact of a history of prior or concomitant upper urinary tract
cancer on the recurrence and progression of non-muscle invasive bladder cancer.
Jpn J Clin Oncol. 2022 Apr 23. pii: 6573315. doi: 10.1093.
PubMed
Abstract available
Bladder Cancer Cells Exert Pleiotropic Effects on Human Adipose-Derived Stem
Cells.
Life (Basel). 2022;12.
PubMed
Abstract available
Mortality from bladder cancer in dyestuff workers exposed to aromatic amines: A
73-year follow-up.
Med Lav. 2022;113:e2022017.
PubMed
Abstract available
Omega-3 polyunsaturated fatty acids: a modified approach for chemo-prevention of
bladder cancer in a rat model and molecular studies of antineoplastic mechanisms.
Mol Biol Rep. 2022 Apr 25. pii: 10.1007/s11033-022-07445.
PubMed
Abstract available
Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to
cisplatin sensitivity in bladder cancer.
Mol Carcinog. 2022 Apr 26. doi: 10.1002/mc.23411.
PubMed
Abstract available
Clinical outcomes associated with expression of aurora kinase and p53 family
members in muscle-invasive bladder cancer.
Mol Clin Oncol. 2022;16:102.
PubMed
Abstract available
Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of
bladder cancer: a case report and review of literature.
Neurol Sci. 2022 Apr 28. pii: 10.1007/s10072-022-06075.
PubMed
Abstract available
Bladder cancer survival in patients with NOD2 or CDKN2A variants.
Oncotarget. 2022;13:628-640.
PubMed
Abstract available
In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene
Signature in Bladder Cancer.
Oxid Med Cell Longev. 2022;2022:3170950.
PubMed
Abstract available
PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using
Both the 22C3 and SP142 Assays.
Pathol Oncol Res. 2022;28:1610260.
PubMed
Abstract available
Swedish national guidelines on urothelial cancer echo the EAU guidelines but with
some regional dialect.
Scand J Urol. 2022;56:147-148.
PubMed
The role of single-nucleotide polymorphisms of the 8q24 chromosome region in
patients with concomitant bladder and prostate cancer.
Scand J Urol. 2022;56:126-130.
PubMed
Abstract available
Anorectal side-effects of radical cystectomy.
Scand J Urol. 2022;56:162-163.
PubMed
MicroRNA signature for estimating the survival time in patients with bladder
urothelial carcinoma.
Sci Rep. 2022;12:4141.
PubMed
Abstract available
Adverse events of different chemotherapy regimens in the first-line treatment of
patients with advanced or metastatic urothelial cancer: A systematic review and
network meta-analysis of randomized controlled trials.
Semin Oncol. 2021;48:181-192.
PubMed
Abstract available
Parastomal skin metastasis in a patient with history of urinary bladder cancer.
Urol Case Rep. 2022;43:102088.
PubMed
Abstract available
Clinical utility of vesical imaging-reporting and data system (VI-RADS) in
non-muscle invasive bladder cancer (NMIBC) patients candidate for en-bloc
transurethral resection: A prospective study.
Urol Oncol. 2022 Apr 21. pii: S1078-1439(22)00099.
PubMed
Abstract available
En bloc resection, is this the future of non-muscle invasive bladder cancer
management? Presentation of our technique and brief review of the literature.
Urologia. 2022 Apr 25:3915603221093739. doi: 10.1177/03915603221093739.
PubMed
Abstract available
Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive
bladder cancer.
Virchows Arch. 2022 Apr 28. pii: 10.1007/s00428-022-03328.
PubMed
Abstract available
T1 bladder carcinoma with variant histology: pathological features and clinical
significance.
Virchows Arch. 2022;480:989-998.
PubMed
Abstract available
Significance of fibulin-3 expression in bladder cancer: a tissue microarray-based
immunohistochemical study.
World J Surg Oncol. 2022;20:133.
PubMed
Abstract available
Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a
comparison with transperitoneal approach.
World J Surg Oncol. 2022;20:130.
PubMed
Abstract available
Accuracy and prognostic value of radiological lymph node features in variant
histologies of bladder cancer.
World J Urol. 2022 Apr 23. pii: 10.1007/s00345-022-04010.
PubMed
Abstract available
Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019.
World J Urol. 2022 Apr 29. pii: 10.1007/s00345-022-04017.
PubMed
Abstract available
Zhejiang Da Xue Xue Bao Yi Xue Ban
Construction of prognosis model of bladder cancer based on transcriptome.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021;50:1-9.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by